BASEL
Switzerland
14
2022-03-31
8
2023-09-19
These are the the leading inventors for applications assigned to ALTAVANT SCIENCES GmbH:
ALTAVANT SCIENCES GmbH based in BASEL, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
#2 | 2022-03-10CRYSTALLINE SPIROCYCLIC COMPOUND, A DOSAGE FORM CONTAINING, A METHOD FOR USING IN TREATMENT OF DISEASE, AND A METHOD FOR RECRYSTALLIZING
#3 | 2022-02-17METHOD FOR TREATING INTERSTITIAL LUNG DISEASE
#4 | 2021-07-08 ✅ Patent 11,759,462 granted on 2023-09-19Spirocyclic compounds as tryptophan hydroxylase inhibitors
#5 | 2021-05-13 ✅ Patent 11,708,365 granted on 2023-07-25Processes for preparing TPH1 inhibitors
#6 | 2020-11-19 ✅ Patent 11,091,763 granted on 2021-08-17Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#7 | 2020-09-17 ✅ Patent 11,576,915 granted on 2023-02-14Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing
#8 | 2020-07-30 ✅ Patent 11,607,413 granted on 2023-03-21Dosage regime and method for treating pulmonary arterial hypertension
#9 | 2020-06-18METHOD FOR TREATING INTERSTITIAL LUNG DISEASE
#10 | 2020-06-18METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
#11 | 2020-05-21 ✅ Patent 11,413,287 granted on 2022-08-16Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
#12 | 2020-05-14 ✅ Patent 11,203,597 granted on 2021-12-21Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing
#13 | 2019-09-19 ✅ Patent 10,660,893 granted on 2020-05-26Spirocyclic compounds as tryptophan hydroxylase inhibitors
#14 | 2019-08-29PROCESSES FOR PREPARING TPH1 INHIBITORS
Also check out ALTAVANT SCIENCES GmbH's (Basel, Switzerland) applicant profile with 8 patent applications submitted.
158418 ⎘